ArticleArchives of rheumatology2026
Clinical Relevance of the HALP Score in Rheumatoid Arthritis: Association with Disease Activity and Inflammatory Burden.
Article in Archives of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsThe hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel biomarker reflecting systemic inflammation and nutritional status. While it has been studied in oncology and some inflammatory diseases, its clinical role in rheumatoid arthritis (RA) remains unclear. This study aimed to investigate the relationship between HALP, disease activity, and inflammatory burden in RA. MATERIALS AND
methodsThis retrospective cross-sectional study included 106 patients with RA diagnosed according to the 2010 ACR/EULAR criteria and 110 age-, sex-, and BMI-matched healthy controls. Clinical and laboratory data were recorded, and HALP scores were calculated. Disease activity was assessed using the disease activity score-28-C-reactive protein (DAS28-CRP). Group comparisons, Spearman correlation analysis, receiveroperating characteristic (ROC) curve analysis, and multivariable logistic regression were performed.
resultsThe HALP scores were significantly lower in patients with RA compared with healthy controls (P < .0001). Among patients with RA, those with active disease exhibited significantly lower HALP scores than those in remission (P < .05), with a decreasing trend across DAS28-CRP disease activity categories. The HALP scores showed negative correlations with CRP (r = -0.329), Visual Analog Scale (VAS)-pain (r = -0.399), and DAS28-CRP (r = -0.348) (all P ≤ .001). The ROC analysis demonstrated moderate discriminative ability for distinguishing active disease from remission (AUC = 0.708, 95% CI: 0.63-0.81). In multivariable logistic regression analysis, lower HALP scores and older age were independently associated with active RA.
conclusionThe study demonstrates that lower HALP scores are associated with higher disease activity in rheumatoid arthritis. As a simple and routinely available laboratory-based index, the HALP score may serve as a supportive marker of inflammatory burden. Prospective multicenter studies are required to validate these findings and to clarify the longitudinal utility of the HALP score. Cite this article as: Çelik G, Çilingiroğlu Ç, Uğur S, Kızıl ŞD. Clinical relevance of the HALP score in rheumatoid arthritis: Association with disease activity and inflammatory burden. Arch Rheumatol. 2026;41(2):134-143.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.